Dr. Vaijinath R. Dhapase is a highly experienced Senior Consultant and HOD of General Medicine with over 24 years of clinical expertise in internal and critical care medicine. He holds MBBS, MD, and DNB qualifications along with advanced certifications in critical care and emergency management.

He specializes in managing diabetes, hypertension, infectious diseases, and critically ill patients. With extensive experience across India and Saudi Arabia, he is known for his evidence-based approach, leadership in ICU care, and active involvement in medical education and public health awareness.

• Diabetes Management
• High Blood Pressure
• Thyroid Management
• Fever – Dengue, Malaria & Typhoid
• Jaundice Treatment
• Pain Management
• Covid Management & Arthritis
• Critical Care

• M.B.B.S from Dr. B A Marathwada University, Aurangabad, India
• M.D. (Gen Med) from Dr. B A Marathwada University, Aurangabad India
• D.N.B. (Gen Med) - Diplomat of National Board, New Delhi, India
• IDCC (I.C.U.) - Indian Society of Intensive care Medicine
• Tubectomy Surgeon - Daga Memorial Hospital, Nagpur, India
• AFIH (Industrial Health) - Director General of Factory and surveillance, Mumbai, Govt. of India.
• MS-CIT (Computer Literacy) - Maharashtra State Knowledge Corporation, Mumbai.

• Working as a Senior Consultant & HOD-Internal Medicine, Park Hospital, Faridabad, Haryana
• Worked as Consultant Internal Medicine, Sarvodaya Hospital, Faridabad, Haryana
• Worked as a Physician in District Health Centre, Beed, Maharashtra, India
• ICU Specialist - Intensive care Unit, Yanbu General Hospital, Saudi Arabia.
• Registrar - Dept of Emergency Medicine, CSH, Jeddah, Saudi Arabia
• Associate Consultant - Dept. of Critical Care Medicine, ICU, Artemis Health Institute, Gurgaon, Haryana, India.
• Senior Resident - Medical intensive care unit in Indraprastha Apollo Hospital, New Delhi

• Diabetes - TOP-TIR Study Benefits of Teneligliptin Beyond Glycemic Control
• Diabetes - Rising Horizon of Teneligliptin Evidences
• Diabetes - Digital CME: Targeting the core defect in Diabetes with Teneligliptin & Pioglitazone”: Focus on Phase 3 evidence
• Antibiotics - Common infection in primary care & it's management: Azithromycin
• Dyslipidaemia - Dyslipidaemia Rosuvastatin Post Marketing Surveillance 2021
• Hypertension - Azeldepin- Post Marketing Surveillance 2021
• Antiepileptics - Levetiracetam- Post Marketing Surveillance 2022
• Water sport Diseases - TV9 Bharatvarsh Digital TV Network Aired on 21st April 2022
• Dangue and Malaria - NavBharat Times